As I posted before, but no one seemed to "pick up" on it. Check out a company called Opthea - especially the CEO...then read between the lines. Is the role of CEO of Prana, one of dynamically leading the way in the development of a new, revolutionary class of drugs or to be the toast of the cocktail party circuit? Here's GK's chance to prove he can lead...or he's in over his head and scrambling.
PBT2 and zinc work together to fight antibiotic resistance, page-92
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
